Result of General Meeting and Total Voting Rights

RNS Number : 1608J
W.H. Ireland Group PLC
18 December 2020
 

WH Ireland Group Plc

 

(“WH Ireland” or the “Company”)

Result of General Meeting

Total Voting Rights

The Company confirms that at today’s General Meeting, all resolutions were duly approved.

Accordingly the Company confirms that the 13,250,000 Ordinary Shares conditionally issued pursuant to the Placing (see announcement dated 30 November 2020) (the “Placing Shares”) have now been allotted, subject only to Admission. As previously announced an application has been made to the London Stock Exchange for admission to trading of the Placing Shares on AIM and dealings are expected to commence on 21 December 2020 (“Admission”).

As also set out in the announcement dated 30 November 2020 and following completion of the Placing, the acquisition of Harspden Wealth Management Limited is anticipated to complete on or around 22 December 2020. A further update will be provided at that time.

For the purposes of the Financial Conduct Authority’s Disclosure and Transparency Rules (“DTRs”), the issued ordinary share capital of the Company following Admission will consist of 61,979,921 Ordinary Shares with voting rights attached (one vote per Ordinary Share). There are no Ordinary Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the DTRs.

For further information please contact:

WH Ireland Group plc                                                             www.whirelandplc.com

Phillip Wale                                                                               +44(0) 20 7220 1666

SPARK Advisory Partners Limited

 

Andrew Emmott

   +44(0) 203 368 3550

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

ROMGPGGPPUPUGUR